Pixels & Pills

Entries Tagged as 'Compliance'

DTC: Death to Commercials

June 25th, 2010 · 4 Comments · Opinion

By Guy Mastrion (@gmastrion)
I’m going to speak heresy as an advertising creative director, specifically one working in healthcare. I’m coming to the belief that the FDA should put an end to branded TV commercials for pharma products.
Why?
Because I believe we’ve all been lulled into a healthcare coma by unimaginative, often nonsensical commercials attempting to communicate [...]

[Read more →]

Tags:·············

Why Healthcare Reform Isn’t Just About Insurance

June 7th, 2010 · 2 Comments · Opinion

(Photo by Win McNamee/Getty Images North America)
By Kimberly Reyes (@CommDuCoeur)
On March 23, 2010, President Obama signed his controversial Healthcare Reform Bill into law, with the objective of making healthcare more affordable and expanding coverage to the 32 million Americans that are currently uninsured, including self-employed individuals and low-income families.
Groups such as Physicians for Reform [...]

[Read more →]

Tags:············

Healthcare Scares

May 10th, 2010 · No Comments · Opinion

This post continues our week-long theme of government regulation with a discussion on why it’s important for consumers to engage with with Pharma companies.
By Russ Ward (@russcward)
Every one of us has done it at least once.
You come down with some sickness, tally up the symptoms of your malady, and hit the internet. Ten minutes later, [...]

[Read more →]

Tags:············

Handling Patient Communities

April 20th, 2010 · 2 Comments · Opinion

This post is part of a week-long series centered around the theme of communication. This week, we’ll identify important communities and provide tips and guidelines on how to effectively reach them.
By Russ Ward (@russcward)
Patient communities are, to many pharma executives, terrifying. They’re the Wild West – an untamed land where people say whatever [...]

[Read more →]

Tags:·················

For The Healthcare Community, There’s An “App” For That

April 2nd, 2010 · 3 Comments · News, Opinion

By Marty Hardin (@mjhardin)
What’s so great about the iPad?
Okay, let’s get this clear up front. I haven’t seen or touched the iPad. But based on 25+ years of using Apple products, a lifetime of observing people, and pretty good instincts, here are my thoughts.
I’ve been hearing vacillating perspectives. Most first-day reactions were: “Yeah, so?” Let’s [...]

[Read more →]

Tags:··············

Location, Location, Location

March 29th, 2010 · 1 Comment · Opinion

By DJ Edgerton (@wiltonbound)
Microblogging? Sooo 2008.
If you listen to the hype that emanated from SXSW, it’s all about location, location, location.
Not very long ago, the idea to make it possible for people to transmit short bursts of information to their group of friends was groundbreaking. Now that Facebook made their status updates a big broader, [...]

[Read more →]

Tags:················

How Comic Books Can Help Us Talk to Doctors

March 16th, 2010 · 4 Comments · Knowledge

By Sven Larsen (@zemoga)
Want to communicate more effectively and quickly with health care providers? Then read a few comic books.
Probably not the advice you were expecting to hear, right? After all, comics are for kids and nerds, adolescent flights of fancy that we put away when we move on to more serious things. And there’s [...]

[Read more →]

Tags:·············

Attention To Detail: The FDA Is Watching You

March 10th, 2010 · 2 Comments · Knowledge, News, Opinion

By Ian DeMeritt, PhD (@idemeritt)
As printed promotional materials are continually being replaced by flashier electronic detail aids and on-line content, it is not surprising that DDMAC continues to cast a regulatory eye on digital presentations of pharmaceutical advertisements. Last April, they fired a resounding shot across the bow of the pharma world that sent a [...]

[Read more →]

Tags:···········

Christiane Truelove on Waiting on the FDA

February 10th, 2010 · 4 Comments · News, Opinion

Live from the E-Pharma Summit (#epharma)
Christiane Truelove of Med Ad News gives her take on how companies are dealing with social media while they’re waiting for the FDA guidelines.

[Read more →]

Tags:··············

Steve Woodruff of Impactiviti on eHarmony and the FDA

February 9th, 2010 · 2 Comments · News, Opinion

Live from the E-Pharma Summit (#epharma)
Steve Woodruff  of Impactiviti talks about what it’s like to be the “eHarmony of the Pharmaceutical industry” and why the FDA should stay away from specifics when it comes to social media guidelines.

[Read more →]

Tags:···············